Date Filed | Type | Description |
08/14/2023 |
4
| Jayasuriya Anula (Director) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Granted 1,718 shares
@ $0 Granted 68,568 shares
@ $0 Granted 1,718 options to buy
@ $0 |
|
08/14/2023 |
4
| Siegel Jonathan B. (Director) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Granted 68,568 shares
@ $0 |
|
08/14/2023 |
4
| MICEK JOHN (Director) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Granted 68,568 shares
@ $0 |
|
08/14/2023 |
4
| BOCHNOWSKI JAMES J (Director) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Granted 76,613 shares
@ $0 |
|
08/14/2023 |
4
| Chaturvedi Pravin R (Chief Scientific Officer) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Granted 204,192 shares
@ $0 |
|
08/14/2023 |
4
| Wolin Jonathan S. (Chief of Staff, CCO & GC) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Granted 196,628 shares
@ $0 |
|
08/14/2023 |
4
| Lizak Carol R. (CFO) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Granted 142,088 shares
@ $0 |
|
08/14/2023 |
4
| King Steven R. (see remarks) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Granted 159,168 shares
@ $0 |
|
08/14/2023 |
4
| CONTE LISA A (CEO and President) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Granted 383,605 shares
@ $0 |
|
05/19/2023 |
4
| Chaturvedi Pravin R (Chief Scientific Officer) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Exercised 870 restricted stock units
@ $0 |
|
05/19/2023 |
4/A
| Chaturvedi Pravin R (Chief Scientific Officer) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Exercised 133 shares
@ $0 Granted 133 restricted stock units
@ $0 |
|
05/19/2023 |
4/A
| Chaturvedi Pravin R (Chief Scientific Officer) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Exercised 10,000 shares
@ $0 Granted 10,000 restricted stock units
@ $0 |
|
05/19/2023 |
4
| Siegel Jonathan B. (Director) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Exercised 1,145 options to buy
@ $0 |
|
05/19/2023 |
4
| MICEK JOHN (Director) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Exercised 1,145 options to buy
@ $0 |
|
05/19/2023 |
4
| BOCHNOWSKI JAMES J (Director) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Exercised 1,280 options to buy
@ $0 |
|
05/19/2023 |
4
| Wolin Jonathan S. (Chief of Staff, CCO & GC) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Exercised 871 restricted stock units
@ $0 |
|
05/19/2023 |
4
| Lizak Carol R. (CFO) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Exercised 431 restricted stock units
@ $0 |
|
05/19/2023 |
4
| King Steven R. (Chief of Sustainable Supply) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Exercised 611 restricted stock units
@ $0 |
|
05/19/2023 |
4
| CONTE LISA A (CEO and President) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Exercised 2,694 restricted stock units
@ $0 |
|
04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/06/2023 |
4
| Jayasuriya Anula (Director) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Granted 1,718 options to buy
@ $0 |
|
01/03/2023 |
4
| Wolin Jonathan S. (Chief of Staff, CCO & GC) has filed a Form 4 on Jaguar Health, Inc.
Txns:
| Bought 317 shares
@ $0.03, valued at
$9.5 |
|
12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2022 |
3
| Jayasuriya Anula (Director) has filed a Form 3 on Jaguar Health, Inc. |
05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|